Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy

Tumor-infiltrating lymphocytes (TIL) has been associated with improved survival in cancer patients. Within the tumor microenvironment, regulatory cells and expression of co-inhibitory immune checkpoint molecules can lead to the inactivation of TIL. Hence, there is a need to develop strategies that d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodumudi, Krithika N., Siegel, Jessica, Weber, Amy M., Scott, Ellen, Sarnaik, Amod A., Pilon-Thomas, Shari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822778/
https://www.ncbi.nlm.nih.gov/pubmed/27050669
http://dx.doi.org/10.1371/journal.pone.0153053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822778/
https://www.ncbi.nlm.nih.gov/pubmed/27050669
http://dx.doi.org/10.1371/journal.pone.0153053

Ejemplares similares